Top Markets
#1 Black Phoenix Black Phoenix +355.13%
#2 Glidr Glidr +84.34%
#3 Gold Park Gold Park +68.86%
#4 OpenEden OpenEden +60.23%
#5 Akedo Akedo +56.95%
#6 BasedHype BasedHype +26.68%
#7 Cryptopia Cryptopia +21.54%
#8 Avantis Avantis +19.51%
#9 Humanity Humanity +19.18%
#10 Ether.fi Ether.fi +17.32%
Coin of the day
Black Phoenix Black Phoenix
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Cyxone AB (publ) Cyxone AB (publ)

Cyxone AB (publ)

CYXO
Clasificación en acciones #40403
Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing... Cyxone AB (publ) is a clinical-stage biotechnology firm focused on developing innovative, disease-modifying therapies. Its primary therapeutic targets include rheumatoid arthritis, multiple sclerosis, and acute respiratory illnesses caused by viruses. The company's pipeline features Rabeximod, currently in Phase II clinical trials for both rheumatoid arthritis and COVID-19. Additionally, T20K, a drug candidate for multiple sclerosis, is undergoing Phase 1 evaluation. Established in 2015, the company is headquartered in Malmö, Sweden.
Precio por acción
$0.00162013
Última sincronización: 2025-01-03
Capitalización bursátil
$156.25K
Cambio (1 día)
0.36%
Cambio (1 año)
0.00%
País
SE
Comercio Cyxone AB (publ) (CYXO)

Categoría

Healthcare
Ratio P/B de Cyxone AB (publ) (CYXO)
Ratio P/B al August 2026 TTM: 0.05
Según los informes financieros más recientes y el precio de las acciones de Cyxone AB (publ), el ratio P/B actual (TTM) es 0.05. Al final de 2022, el ratio P/B era 0.95.
Historial del ratio P/B de Cyxone AB (publ) desde 2015 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
2026 (TTM) 0.05 -80.68%
2023 0.25 -73.81%
2022 0.95 -62.04%
2021 2.50 -27.47%
2020 3.45 49.69%
2019 2.31 74.16%
2018 1.32 -75.84%
2017 5.48 22.16%
2016 4.49 -98.16%
2015 243.41 0.00%
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 12,863.35%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 13,043.48%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 7,423.81%
BE